Statistics for National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey
Total visits
| views | |
|---|---|
| National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey | 0 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |